Volcano buys cath imaging firm

Volcano is acquiring Sync-Rx, an Israeli software developer that focuses on coronary catheterizations, in a deal reported to total $17.3 million.

Volcano announced Nov. 23 that it entered into a definitive agreement to acquire the privately-held company and anticipated the transaction will close within the next 30 days. Netanya, Israel-based Sync-Rx develops software applications and manufactures image-guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease.

Its products include the Sync-Rx System, an add-on online image processing workstation for coronary catheterizations that has received FDA 510(k) clearance and CE Mark in Europe.

Scott Huennekens, Volcano’s president and CEO, described the transaction as a move to advance Volcano’s platform and broaden the San Diego-based company’s reach in Israel. He added that the acquisition will allow Volcano to build software features to assist in clinical decision-making by providing angiography and intra-body image enhancement.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup